GDTC
GDTC
NASDAQ · Biotechnology

Cytomed Therapeutics Ltd

$0.82
+0.04 (+4.55%)
As of May 16, 2:28 AM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +2,881.0% upside
Low Target $15.00
Average Target $24.31
High Target $29.94
Current Price $0.82
Current
$0.82
Target
$24.31
$15.00 $24.31 avg $29.94
Scenario Analysis
Bear Case
$15.00
1,739.4%
Low target
Base Case
$24.31
+2,881.0%
Avg target
Bull Case
$29.94
+3,571.4%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$3.68
-77.8% from high
52-Week Low
$0.68
+19.9% from low
Target vs 52W High
$24.31
+560.6% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 75% $257.58 +22.4%
AMGN
Amgen Inc
Hold 44 48% $190.87 -41.5%
GILD
Gilead Sciences Inc
Strong Buy 39 79% $362.68 +179.9%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 +0.3%
REGN
Regeneron Pharmaceuticals
Strong Buy 38 79% $76.80 -89.0%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 75% $102.31 -64.3%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -21.7%
BIIB
Biogen Inc
Buy 43 56% $91.45 -52.6%